Decheng Capital LLC Portfolio Holdings

Decheng Capital LLC

  • $746 Billion
  • Q1 2024

Decheng Capital LLC has filed its 13F form on May 13, 2024 for Q1 2024 where it was disclosed a total value porftolio of $746 Billion distributed in 22 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Alpine Immune Sciences, Inc. with a value of $330B, Cg Oncology Inc with a value of $240B, Zentalis Pharmaceuticals, Inc. with a value of $33.1B, Illumina, Inc. with a value of $17.7B, and Beyond Spring Inc. with a value of $17.7B.

Examining the 13F form we can see an increase of $388B in the current position value, from $358B to 746B.

Decheng Capital LLC is based out at Menlo Park, CA

Below you can find more details about Decheng Capital LLC portfolio as well as his latest detailed transactions.

Portfolio value $746 Billion
Healthcare: $497 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$0
$330 Billion 44.22% of portfolio
8,317,924
Q1 2024 Added 17.43%
Cg Oncology Inc
-
$240 Billion 32.14% of portfolio
-
Q1 2024 New
$677M
$33.1 Billion 4.44% of portfolio
2,099,583
Q4 2023 New
$16.4B
$17.7 Billion 2.38% of portfolio
129,067
Q1 2024 Added 59.62%
$102M
$17.7 Billion 2.37% of portfolio
4,958,143
Q4 2023 New
$1.09B
$16.4 Billion 2.2% of portfolio
869,790
Q4 2023 New
$4.11B
$11.7 Billion 1.57% of portfolio
65,772
Q4 2023 New
$776M
$11.1 Billion 1.49% of portfolio
347,835
Q1 2024 New
$51.5M
$10.3 Billion 1.38% of portfolio
4,447,308
Q4 2023 New
$369M
$9.03 Billion 1.21% of portfolio
850,000
Q4 2023 New
Moonlake Immunotherapeutics
-
$8.37 Billion 1.12% of portfolio
-
Q1 2024 New
$2.13B
$7.35 Billion 0.99% of portfolio
195,835
Q1 2024 Reduced 45.53%
$2.39B
$7.39 Billion 0.99% of portfolio
157,958
Q1 2024 New
$4.57B
$6.59 Billion 0.88% of portfolio
94,043
Q1 2024 New
$6.7B
$4.84 Billion 0.65% of portfolio
86,363
Q1 2024 New
$2.44B
$4.58 Billion 0.61% of portfolio
101,798
Q1 2024 New
$10.4M
$1.7 Billion 0.23% of portfolio
8,980,909
Q4 2023 New
$131M
$1.39 Billion 0.19% of portfolio
326,810
Q4 2023 New
$37.8M
$1.23 Billion 0.17% of portfolio
526,329
Q4 2023 New
Gene Dx Holdings Corp.
-
$946 Million 0.13% of portfolio
-
Q4 2023 New
$1.05B
$815 Million 0.11% of portfolio
26,797
Q1 2024 Reduced 42.07%

Summary

  • Portfolio
  • No. of Stocks 22
  • Current Value $746 Billion
  • Prior Value $358 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 13, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 7 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Decheng Capital LLC Portfolio

Follow Decheng Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decheng Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decheng Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email